Showing results (2691-2700 of 3,166) with videos related to

Sort By:
Pageof 317
Neuro-Oncology|April 17, 2018
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastomaBenjamin M Ellingson, Dana T Aftab, Gisela M Schwab, et al.
Neuro-Oncology|June 6, 2018
Arterial spin labeling MR imaging for differentiation between high- and low-grade glioma-a meta-analysisAlberto Falk Delgado, Francesca De Luca, Danielle van Westen, et al.
Neuro-Oncology|June 19, 2018
An oncolytic measles virus-sensitive Group 3 medulloblastoma model in immune-competent miceSangeet Lal, Diego Carrera, Joanna J Phillips, et al.
Neuro-Oncology|March 18, 2009
REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapyHuibo Wang, Shu-Yu Zhang, Shuai Wang, et al.
Neuro-Oncology|March 19, 2009
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
Neuro-Oncology|February 24, 2009
Occupational exposure to magnetic fields and the risk of brain tumorsJoseph B Coble, Mustafa Dosemeci, Patricia A Stewart, et al.
Neuro-Oncology|August 21, 2008
Quality of life in low-grade glioma patients receiving temozolomideRaymond Liu, Karla Solheim, Mei-Yin Polley, et al.
Neuro-Oncology|October 31, 2008
Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma modelQingyu Zhou, James M Gallo
Neuro-Oncology|January 14, 2009
Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenograftsJ Graeme Hodgson, Ru-Fang Yeh, Amrita Ray, et al.
Neuro-Oncology|January 27, 2009
MRI assessment of hemodynamic effects of angiopoietin-2 overexpression in a brain tumor modelSamuel Valable, Dauphou Eddi, Jean-Marc Constans, et al.
Pageof 317